| Endogenous sex hormones and cardiovascular disease in men. | |
| | |
MedLine Citation:
|
PMID: 14602729 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Unlike women, men do not experience an abrupt reduction in endogenous sex hormone production. It has, however, become clear that an age-associated decrease in the levels of (bioactive) sex hormones does occur. Whether endogenous sex hormones have an impact on cardiovascular disease has for many years remained largely unknown, but during the last decade more attention has been drawn to the importance of testosterone, estrogens, and adrenal androgens in etiology, prevention, and treatment of male cardiovascular disease. The purpose of this article is to summarize the evidence currently available on the association between endogenous sex hormones and cardiovascular disease in males. Published studies dealing with the relationship between circulating levels of sex hormones and cardiovascular disease in males were reviewed. The studies reviewed in this article suggest that circulating endogenous sex hormones and estrogens have a neutral or beneficial effect on cardiovascular disease in men. |
| | |
Authors:
|
Majon Muller; Yvonne T van der Schouw; Jos H H Thijssen; Diederick E Grobbee |
Related Documents
:
|
19777939 - Cardiovascular care: a challenge for kentucky. 14615369 - Cause-effect relation between hyperfibrinogenemia and vascular disease. 19065999 - Detection of metabolic syndrome features among childhood cancer survivors: a target to ... 16391539 - Erectile dysfunction as an early sign of cardiovascular disease. 19892309 - Diagnostic performance in a primary referral hospital assessed by autopsy: evolution ov... 16291069 - Responding to the threat of chronic diseases in india. 9860819 - Study on exposure of pig farm workers to bioaerosols, immunologic reactivity and health... 2823779 - Adenovirus infection associated with respiratory disease in commercial chickens. 18492229 - Human methanogen diversity and incidence in healthy and diseased colonic groups using m... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 88 ISSN: 0021-972X ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2003 Nov |
Date Detail:
|
Created Date: 2003-11-06 Completed Date: 2003-12-09 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 5076-86 Citation Subset: AIM; IM |
Affiliation:
|
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiovascular Diseases
/
epidemiology*,
metabolism* Dehydroepiandrosterone / metabolism* Humans Male Risk Factors Testosterone / metabolism* |
| Chemical | |
Reg. No./Substance:
|
53-43-0/Dehydroepiandrosterone; 58-22-0/Testosterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical review 165: Markers of bone remodeling in metastatic bone disease.
Next Document: Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell ...